Delivery Order SPE2DB22D2206-SPE2DB25FGM95

Award Date 4/10/25
Potential Completion Date 5/1/25
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Mekinist 0.5 mg tablets. The contract, which is not set aside, has a ceiling value of $2,589.70 and a completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including specialty medications, branded and generic drugs, vaccines, and...
This is a $8,878.79 firm fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide 4563518616 Mekinist 2 mg tablets, with a completion date of February 23, 2024. This contract is a part of AmerisourceBergen's broader Indefinite Delivery Contract with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $6,064.14 firm fixed price order is for the supply of Mekinist 0.05 mg/ml solution, a prescription medication. This order is part of a larger, indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a potential value of...
The U.S. Defense Logistics Agency (DLA) awarded a $5,053.45 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply Mekinist 0.05 mg/ml solution 90ml. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,670.51 firm fixed-price delivery order is for the supply of MEKINIST 2 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order under a Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at up to $999,999,999 through December 2025, provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This specific delivery order, valued at $8,878.79, is for the Mekinist 2 mg tablet drug product. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MEKINIST 2 MG TABLET UU 30S, a prescription medication. The award, valued at $17,757.60, has an ultimate completion date of August 28, 2024. It is a firm-fixed-price contract and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of MEKINIST 2 MG tablets, a prescription medication, with a ceiling value of $82,134.30 and a completion date of February 28, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business category. Amerisourcebergen holds a larger...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of MEKINIST 2 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,878.79 firm fixed price delivery order was issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $2,589.70 by the Defense Logistics Agency (DLA) to provide MEKINIST 0.5 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGM95
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Mekinist 0.5 mg tablet. The contract has a firm fixed price of $8,552.49 and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely one of many orders placed under that larger IDC to support military and veteran healthcare systems.

Generated 7/17/25, 5:58 PM